Is there an association between liraglutide use and female breast cancer in a real-world setting?

Funch, D; Mortimer, K; Li, L; Norman, H; Major-Pedersen, A; Olsen, AH; Kaltoft, MS; Dore, DD

Dore, DD (reprint author), Optum Epidemiol, 1325 Boylston St,10th Floor, Boston, MA 02215 USA.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018; 11 (): 791

Abstract

Background: Liraglutide is a human glucagon-like peptide-1 receptor agonist approved for treatment of adults with type 2 diabetes mellitus at a maximu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索